Axogen Inc Market Cap ($2.25 Billion)
Market Cap & Net Worth: Axogen Inc (AXGN)
Axogen Inc market cap. Axogen Inc (NASDAQ:AXGN) has a market capitalization of $2.25 Billion ($2.25 Billion) as of November 5, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #5597 globally and #1848 in its home market, demonstrating a 37.08% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Axogen Inc's stock price $51.35 by its total outstanding shares 53177824 (53.18 Million). Also see Axogen Inc cash conversion from operations for how efficiently the company converts equity into cash flow.
Axogen Inc Market Cap History (2015–2026)
Axogen Inc market cap history from 2015 to 2026. Data shows growth from $265.89 Million to $2.73 Billion (24.15% CAGR). Check latest Axogen Inc stock price today for real-time trading data and today's change.
Index Memberships
Axogen Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.62 Trillion | 0.09% | #150 of 976 |
|
NASDAQ Composite
IXIC
|
$40.12 Trillion | 0.01% | #631 of 3165 |
Weight: Axogen Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Axogen Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Axogen Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore AXGN year-over-year net asset growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
7.73x
Axogen Inc's market cap is 7.73 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $478.60 Million | $41.11 Million | -$14.41 Million | 11.64x | N/A |
| 2017 | $1.50 Billion | $60.43 Million | -$10.45 Million | 24.91x | N/A |
| 2018 | $1.09 Billion | $83.94 Million | -$22.40 Million | 12.94x | N/A |
| 2019 | $951.35 Million | $106.71 Million | -$29.12 Million | 8.92x | N/A |
| 2020 | $951.88 Million | $112.30 Million | -$23.79 Million | 8.48x | N/A |
| 2021 | $498.28 Million | $127.36 Million | -$26.98 Million | 3.91x | N/A |
| 2022 | $530.71 Million | $138.58 Million | -$28.95 Million | 3.83x | N/A |
| 2023 | $363.20 Million | $159.01 Million | -$21.72 Million | 2.28x | N/A |
| 2024 | $876.37 Million | $187.34 Million | -$9.96 Million | 4.68x | N/A |
| 2025 | $1.74 Billion | $225.21 Million | -$15.70 Million | 7.73x | N/A |
Competitor Companies of AXGN by Market Capitalization
Companies near Axogen Inc in the global market cap rankings as of November 5, 2026. Also see total assets of Axogen Inc for a full breakdown of the balance sheet.
Key companies related to Axogen Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #107 globally with a market cap of $196.11 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #182 globally with a market cap of $130.04 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #225 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #237 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #107 | Abbott Laboratories | NYSE:ABT | $196.11 Billion | $115.51 |
| #182 | Stryker Corporation | NYSE:SYK | $130.04 Billion | $339.65 |
| #225 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $104.96 |
| #237 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Axogen Inc (2015–2026)
Market capitalization of Axogen Inc from 2015 to today. Between 2015 and today, Axogen Inc's market cap moved from $265.89 Million to $ 2.73 Billion, with a yearly change of 24.15%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $2.73 Billion | +56.89% |
| 2025 | $1.74 Billion | +98.60% |
| 2024 | $876.37 Million | +141.29% |
| 2023 | $363.20 Million | -31.56% |
| 2022 | $530.71 Million | +6.51% |
| 2021 | $498.28 Million | -47.65% |
| 2020 | $951.88 Million | +0.06% |
| 2019 | $951.35 Million | -12.43% |
| 2018 | $1.09 Billion | -27.81% |
| 2017 | $1.50 Billion | +214.44% |
| 2016 | $478.60 Million | +80.00% |
| 2015 | $265.89 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 5th, 2026 the market cap of Axogen Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.25 Billion USD |
| MoneyControl | $2.25 Billion USD |
| MarketWatch | $2.25 Billion USD |
| marketcap.company | $2.25 Billion USD |
| Reuters | $2.25 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Axogen Inc
Axogen, Inc., together with its subsidiaries, engages in the development and commercialization of the technologies used for peripheral nerve regeneration and repair worldwide. The company offers Avance Nerve Graft, a processed nerve allograft intended for the surgical repair of peripheral nerve discontinuities; Axoguard Nerve Connector, a coaptation aid used to align and connect severed periphera… Read more